BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23621765)

  • 21. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.
    Birlik M; Akar S; Tuzel E; Onen F; Ozer E; Manisali M; Kirkali Z; Akkoc N
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):122-5. PubMed ID: 14745551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of gemcitabine in the treatment of bladder tumors].
    Cortesi E; Gareri R
    Clin Ter; 1999; 150(1):5-6. PubMed ID: 10367537
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin in superficial bladder cancer: a preliminary study.
    Cho DY; Bae JH; Moon DG; Cheon J; Lee JG; Kim JJ; Yoon DK; Park HS
    J Int Med Res; 2009; 37(6):1823-30. PubMed ID: 20146880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gemcitabine and urogenital tumors].
    Culine S
    Bull Cancer; 2002 Aug; 89 Spec No():S102-6. PubMed ID: 12449039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study.
    Mattioli F; Curotto A; Manfredi V; Gosmar M; Garbero C; Ambruosi C; Carmignani G; Martelli A
    Anticancer Res; 2005; 25(3c):2493-6. PubMed ID: 16080482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
    Herman JM; Smith DC; Montie J; Hayman JA; Sullivan MA; Kent E; Griffith KA; Esper P; Sandler HM
    Urology; 2004 Jul; 64(1):69-73. PubMed ID: 15245938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining patient preferences for improved chemotoxicity during treatment for advanced bladder cancer.
    Aristides M; Von Der Maase H; Roberts T; Brown A; Kielhorn A; Bhalla S
    Eur J Cancer Care (Engl); 2005 May; 14(2):141-2. PubMed ID: 15842461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.
    Borut K; Lijana ZK
    Radiother Oncol; 2012 Mar; 102(3):412-5. PubMed ID: 21890225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine induced digital ischaemia and necrosis.
    Holstein A; Bätge R; Egberts EH
    Eur J Cancer Care (Engl); 2010 May; 19(3):408-9. PubMed ID: 19490003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case report: Acro-necrosis of the upper limbs caused by gemcitabine therapy].
    D'Alessandro V; Errico M; Varriale A; Greco A; De Cata A; Carnevale V; Grilli M; De Luca P; Brucoli I; Susi M; Camagna A
    Clin Ter; 2003; 154(3):207-10. PubMed ID: 12910811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder.
    Campodonico F; Maffezzini M
    Urology; 2005 Nov; 66(5):1141-2; author reply 1142. PubMed ID: 16286156
    [No Abstract]   [Full Text] [Related]  

  • 32. Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.
    Galsky MD; Hahn NM; Powles T; Hellerstedt BA; Lerner SP; Gardner TA; Yu M; O'Rourke M; Vogelzang NJ; Kocs D; McKenney SA; Melnyk AM; Hutson TE; Rauch M; Wang Y; Asmar L; Sonpavde G
    Clin Genitourin Cancer; 2013 Jun; 11(2):175-81. PubMed ID: 23228446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
    Shelley M; Cleves A; Wilt TJ; Mason M
    Cochrane Database Syst Rev; 2011 Apr; (4):CD008976. PubMed ID: 21491413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel.
    Matsui Y; Fujikawa K; Iwamura H; Oka H; Fukuzawa S; Takeuchi H
    Int J Urol; 2002 Feb; 9(2):122-4. PubMed ID: 12033198
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].
    Cao M; Ma CK; Ma J; Chen HG; Xue W
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):385-7. PubMed ID: 21875472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Generalized Exanthematous Pustulosis Induced by Amoxicillin/Clavulanic Acid: Report of a Case Presenting With Generalized Lymphadenopathy.
    Syrigou E; Grapsa D; Charpidou A; Syrigos K
    J Cutan Med Surg; 2015; 19(6):592-4. PubMed ID: 25997755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
    Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute generalized exanthematous pustulosis caused by ibuprofen-Diagnosis confirmed by patch testing.
    Belz D; Persa OD; Haese S; Hunzelmann N
    Contact Dermatitis; 2018 Jul; 79(1):40-41. PubMed ID: 29572854
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute generalized exanthematous pustulosis due to terbinafine.
    Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K
    Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravesical gemcitabine for non-muscle invasive bladder cancer].
    Krabbe LM; Schmidt S
    Urologe A; 2015 Mar; 54(3):402-5. PubMed ID: 25700862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.